These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17434520)

  • 1. The role of muscles in joint degeneration and osteoarthritis.
    Herzog W; Longino D
    J Biomech; 2007; 40 Suppl 1():S54-63. PubMed ID: 17434520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed model of botulinum toxin-induced muscle weakness in the rabbit.
    Longino D; Frank C; Leonard TR; Vaz MA; Herzog W
    J Orthop Res; 2005 Nov; 23(6):1411-8. PubMed ID: 15935608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botox produces functional weakness in non-injected muscles adjacent to the target muscle.
    Yaraskavitch M; Leonard T; Herzog W
    J Biomech; 2008; 41(4):897-902. PubMed ID: 18184613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of electrical stimulation exercise on muscles injected with botulinum toxin type-A (botox).
    Fortuna R; Horisberger M; Vaz MA; Van der Marel R; Herzog W
    J Biomech; 2013 Jan; 46(1):36-42. PubMed ID: 23122225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute botulinum toxin-induced muscle weakness in the anterior cruciate ligament-deficient rabbit.
    Longino D; Frank C; Herzog W
    J Orthop Res; 2005 Nov; 23(6):1404-10. PubMed ID: 15913943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and length-dependent effects of Botulinum toxin-induced muscle weakness.
    Longino D; Butterfield TA; Herzog W
    J Biomech; 2005 Mar; 38(3):609-13. PubMed ID: 15652561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle weakness causes joint degeneration in rabbits.
    Rehan Youssef A; Longino D; Seerattan R; Leonard T; Herzog W
    Osteoarthritis Cartilage; 2009 Sep; 17(9):1228-35. PubMed ID: 19427403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of muscle weakness and joint inflammation on the onset and progression of osteoarthritis in the rabbit knee.
    Egloff C; Sawatsky A; Leonard T; Hart DA; Valderrabano V; Herzog W
    Osteoarthritis Cartilage; 2014 Nov; 22(11):1886-93. PubMed ID: 25106675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do skeletal muscle properties recover following repeat onabotulinum toxin A injections?
    Fortuna R; Horisberger M; Vaz MA; Herzog W
    J Biomech; 2013 Sep; 46(14):2426-33. PubMed ID: 23953503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in contractile properties of muscles receiving repeat injections of botulinum toxin (Botox).
    Fortuna R; Vaz MA; Youssef AR; Longino D; Herzog W
    J Biomech; 2011 Jan; 44(1):39-44. PubMed ID: 20828699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water-soluble C60 fullerene prevents degeneration of articular cartilage in osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development.
    Yudoh K; Shishido K; Murayama H; Yano M; Matsubayashi K; Takada H; Nakamura H; Masuko K; Kato T; Nishioka K
    Arthritis Rheum; 2007 Oct; 56(10):3307-18. PubMed ID: 17907184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of muscles in joint adaptation and degeneration.
    Herzog W; Longino D; Clark A
    Langenbecks Arch Surg; 2003 Oct; 388(5):305-15. PubMed ID: 14504930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations on joint and articular cartilage mechanics.
    Herzog W; Federico S
    Biomech Model Mechanobiol; 2006 Jun; 5(2-3):64-81. PubMed ID: 16534622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular aspects of osteoarthritis: a perspective.
    Brandt KD
    Novartis Found Symp; 2004; 260():49-58; discussion 58-63, 100-4, 277-9. PubMed ID: 15283443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
    Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased efficacy and decreased systemic-effects of botulinum toxin A injection after active or passive muscle manipulation.
    Minamoto VB; Hulst JB; Lim M; Peace WJ; Bremner SN; Ward SR; Lieber RL
    Dev Med Child Neurol; 2007 Dec; 49(12):907-14. PubMed ID: 18039237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation patterns of two degradation enzyme systems in articular cartilage in different stages of osteoarthritis: regulation by dehydroepiandrosterone.
    Bao JP; Chen WP; Feng J; Zhao J; Shi ZL; Huang K; Wu LD
    Clin Chim Acta; 2009 Oct; 408(1-2):1-7. PubMed ID: 19589338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth effects of botulinum toxin type A injected into masseter muscle on a developing rat mandible.
    Kim JY; Kim ST; Cho SW; Jung HS; Park KT; Son HK
    Oral Dis; 2008 Oct; 14(7):626-32. PubMed ID: 18331419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of botulinum toxin A-induced paralysis and exercise training on mechanosensing and signalling gene expression in juvenile rat gastrocnemius muscle.
    Velders M; Legerlotz K; Falconer SJ; Stott NS; McMahon CD; Smith HK
    Exp Physiol; 2008 Dec; 93(12):1273-83. PubMed ID: 18603602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of OA kneepad on apoptosis genes Bcl-2 and p53 expression in articular cartilage cells of experimental knee osteoarthritis].
    Lin MN; Liu XX; Wang SL; Lan FH; Li XH; Liu JH
    Zhongguo Gu Shang; 2009 Sep; 22(9):688-91. PubMed ID: 19817204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.